| P50 | author | Kevin G. Becker | Q30347672 |
| | Elin Lehrmann | Q50421331 |
| P2093 | author name string | Anumantha G Kanthasamy | |
| | Arthi Kanthasamy | |
| | Vellareddy Anantharam | |
| | Yongjie Yang | |
| | Probal Banerjee | |
| | William J Freed | |
| P2860 | cites work | The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis | Q24622720 |
| | Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit | Q24678549 |
| | alpha-Synuclein shares physical and functional homology with 14-3-3 proteins | Q28139698 |
| | Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A | Q28641016 |
| | Oxidative stress in Parkinson's disease | Q29618017 |
| | Molecular Pathways of Neurodegeneration in Parkinson's Disease | Q29619903 |
| | MAPK cascade signalling and synaptic plasticity | Q29619955 |
| | Analysis of microarray data using Z score transformation | Q30787499 |
| | Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism | Q31961819 |
| | Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells | Q32063604 |
| | 14-3-3 proteins in the nervous system | Q33188355 |
| | Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. | Q33195171 |
| | Signal transduction by heme-containing PAS-domain proteins | Q33975037 |
| | Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. | Q34117201 |
| | Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias | Q34254439 |
| | BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer | Q34343195 |
| | Transcriptional interactions between yeast tRNA genes, flanking genes and Ty elements: a genomic point of view. | Q34374018 |
| | The cytoskeleton in neurodegenerative diseases | Q34446779 |
| | Mapping of the human PAWR (par-4) gene to chromosome 12q21. | Q34477431 |
| | Apoptotic molecules and MPTP-induced cell death | Q34802059 |
| | Genes and oxidative stress in parkinsonism: cDNA microarray studies. | Q35004705 |
| | Apoptosis in Parkinson's disease: signals for neuronal degradation | Q35094891 |
| | Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs | Q35111639 |
| | Protein kinase Cdelta regulates apoptosis via activation of STAT1. | Q45025040 |
| | Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra. | Q45030456 |
| | Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease | Q46682616 |
| | Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease. | Q48540299 |
| | Hypoxia, BNip3 proteins, and the mitochondrial death pathway in cardiomyocytes | Q51707686 |
| | Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes | Q59508508 |
| | NOS knockouts and neuroprotection | Q64819984 |
| | Par-4 keeps the atypical PKCs at bay | Q73270715 |
| | Microarray analysis in Alzheimer's disease and normal aging | Q80570828 |
| | Emerging role of Mcl-1 in actively counteracting BH3-only proteins in apoptosis | Q83289839 |
| | The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease | Q35171029 |
| | Neuroprotective strategies in Parkinson's disease : an update on progress | Q35182054 |
| | The use of microarrays to characterize neuropsychiatric disorders: postmortem studies of substance abuse and schizophrenia | Q35207357 |
| | What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease? | Q35208309 |
| | Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis | Q35547471 |
| | Role of Proteolytic Activation of Protein Kinase Cδ in Oxidative Stress-Induced Apoptosis | Q35568824 |
| | Molecular pathways to neurodegeneration | Q35844771 |
| | A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. | Q35858005 |
| | Pathogenetic mechanisms of parkin in Parkinson's disease | Q35869639 |
| | Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L. | Q35897178 |
| | Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs | Q35906130 |
| | Synucleins and their relationship to Parkinson's disease. | Q35926973 |
| | Molecular pathophysiology of Parkinson's disease | Q36196507 |
| | Mitochondria take center stage in aging and neurodegeneration | Q36264218 |
| | Expanding insights of mitochondrial dysfunction in Parkinson's disease. | Q36404133 |
| | Parkin blushed by PINK1. | Q36479140 |
| | Microarrays in Parkinson's disease: a systematic approach | Q36525157 |
| | Specific up-regulation of GADD153/CHOP in 1-methyl-4-phenyl-pyridinium-treated SH-SY5Y cells | Q38287291 |
| | Microarray expression analysis of gad mice implicates involvement of Parkinson's disease associated UCH-L1 in multiple metabolic pathways | Q38339885 |
| | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells | Q38341590 |
| | Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death | Q40405034 |
| | Selective alterations of gene expression in mice induced by MPTP. | Q40473872 |
| | Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma | Q40499829 |
| | Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells | Q40506963 |
| | Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude mice | Q40527701 |
| | UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease | Q40540062 |
| | Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons | Q40549467 |
| | Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration | Q40576585 |
| | Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron | Q40592358 |
| | Caspase‐3 dependent proteolytic activation of protein kinase Cδ mediates and regulates 1‐methyl‐4‐phenylpyridinium (MPP+)‐induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration | Q40631358 |
| | Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons | Q40669010 |
| | Oxidative stress and mitochondrial-mediated apoptosis in dopaminergic cells exposed to methylcyclopentadienyl manganese tricarbonyl | Q40724955 |
| | Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins. | Q40929140 |
| | Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism: a review | Q41000320 |
| | Apoptosis is associated with an increase in saturated fatty acid containing phospholipids in the neuronal cell line, HN2-5. | Q41145279 |
| | Immortalized GABAergic cell lines derived from rat striatum using a temperature-sensitive allele of the SV40 large T antigen. | Q41510297 |
| | Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival. | Q42467478 |
| | Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine | Q43658577 |
| | DNA microarray analysis of the contused spinal cord: effect of NMDA receptor inhibition | Q43981146 |
| | Methamphetamine-induced dopaminergic neurotoxicity and production of peroxynitrite are potentiated in nerve growth factor differentiated pheochromocytoma 12 cells. | Q44053597 |
| | JunB and Bcl-2 overexpression results in protection against cell death of nigral neurons following axotomy | Q44133691 |
| | Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum | Q44149297 |
| | 14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta. | Q44247686 |
| | The mouse MPTP model: gene expression changes in dopaminergic neurons | Q44282749 |
| | Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration | Q44494831 |
| | Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter | Q44674289 |
| | Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades | Q44760486 |
| | Biomedicine. Parkinson's--divergent causes, convergent mechanisms. | Q44904985 |
| P433 | issue | 6 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| | dopamine | Q170304 |
| P304 | page(s) | 834-847 | |
| P577 | publication date | 2007-02-23 | |
| P1433 | published in | Neurochemistry International | Q7002160 |
| P1476 | title | Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease | |
| P478 | volume | 50 | |